Traxxsson Traxxsson is developing proprietary molecular tests to diagnose and stage cancer. The assays developed by Traxxsson are targeted to allow clinicians to tailor therapy for each patient, and to monitor treatment for success.
Member count: 11-50
Investors 1
| Date | Name | Website |
| - | Missouri T... | missourite... |